| Stage | ENB | % of rev | DUK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $14.8B | 100.00% | $7.6B | 100.00% | ENB ×1.95 |
| Gross profit | $4.3B | 28.91% | $4.2B | 54.82% | DUK +25.9pp |
| Operating income | $1.5B | 10.14% | $2.0B | 26.99% | DUK +16.8pp |
| Pre-tax income | $1.3B | 8.91% | $1.3B | 17.19% | DUK +8.3pp |
| Net income | $1.0B | 6.84% | $1.1B | 15.08% | DUK +8.2pp |
| Stage | ENB | DUK | Gap · A − B |
|---|---|---|---|
| Revenue | $14.8B100.00% | $7.6B100.00% | ENB ×1.95 |
| Gross profit | 28.91%$4.3B | 54.82%$4.2B | DUK +25.9pp |
| Operating income | 10.14%$1.5B | 26.99%$2.0B | DUK +16.8pp |
| Pre-tax income | 8.91%$1.3B | 17.19%$1.3B | DUK +8.3pp |
| Net income |
| 6.84%$1.0B |
| 15.08%$1.1B |
| DUK +8.2pp |
No shared counterparties.